986 related articles for article (PubMed ID: 22520847)
1. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease.
O'Shea JJ; Plenge R
Immunity; 2012 Apr; 36(4):542-50. PubMed ID: 22520847
[TBL] [Abstract][Full Text] [Related]
2. The JAK-STAT pathway at 30: Much learned, much more to do.
Philips RL; Wang Y; Cheon H; Kanno Y; Gadina M; Sartorelli V; Horvath CM; Darnell JE; Stark GR; O'Shea JJ
Cell; 2022 Oct; 185(21):3857-3876. PubMed ID: 36240739
[TBL] [Abstract][Full Text] [Related]
3. Targeting the JAK-STAT pathway in autoimmune diseases and cancers: A focus on molecular mechanisms and therapeutic potential.
Tzeng HT; Chyuan IT; Lai JH
Biochem Pharmacol; 2021 Nov; 193():114760. PubMed ID: 34492272
[TBL] [Abstract][Full Text] [Related]
4. Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases.
Yan Z; Gibson SA; Buckley JA; Qin H; Benveniste EN
Clin Immunol; 2018 Apr; 189():4-13. PubMed ID: 27713030
[TBL] [Abstract][Full Text] [Related]
5. The JAK/STAT signaling pathway: from bench to clinic.
Hu X; Li J; Fu M; Zhao X; Wang W
Signal Transduct Target Ther; 2021 Nov; 6(1):402. PubMed ID: 34824210
[TBL] [Abstract][Full Text] [Related]
6. Targeting cytokine signaling in autoimmunity: back to the future and beyond.
Hirahara K; Schwartz D; Gadina M; Kanno Y; O'Shea JJ
Curr Opin Immunol; 2016 Dec; 43():89-97. PubMed ID: 27821272
[TBL] [Abstract][Full Text] [Related]
7. JAK/STAT disruption induces immuno-deficiency: Rationale for the development of JAK inhibitors as immunosuppressive drugs.
Cornez I; Yajnanarayana SP; Wolf AM; Wolf D
Mol Cell Endocrinol; 2017 Aug; 451():88-96. PubMed ID: 28131742
[TBL] [Abstract][Full Text] [Related]
8. JAK/STAT signaling in regulation of innate lymphoid cells: The gods before the guardians.
Stabile H; Scarno G; Fionda C; Gismondi A; Santoni A; Gadina M; Sciumè G
Immunol Rev; 2018 Nov; 286(1):148-159. PubMed ID: 30294965
[TBL] [Abstract][Full Text] [Related]
9. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer.
Xue C; Yao Q; Gu X; Shi Q; Yuan X; Chu Q; Bao Z; Lu J; Li L
Signal Transduct Target Ther; 2023 May; 8(1):204. PubMed ID: 37208335
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Jak/STAT signaling in immunity and disease.
Villarino AV; Kanno Y; Ferdinand JR; O'Shea JJ
J Immunol; 2015 Jan; 194(1):21-7. PubMed ID: 25527793
[TBL] [Abstract][Full Text] [Related]
11. JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects.
Banerjee S; Biehl A; Gadina M; Hasni S; Schwartz DM
Drugs; 2017 Apr; 77(5):521-546. PubMed ID: 28255960
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic targeting of the Jak/STAT pathway.
Aittomäki S; Pesu M
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):18-23. PubMed ID: 24164900
[TBL] [Abstract][Full Text] [Related]
13. The JAK-STAT pathway: impact on human disease and therapeutic intervention.
O'Shea JJ; Schwartz DM; Villarino AV; Gadina M; McInnes IB; Laurence A
Annu Rev Med; 2015; 66():311-28. PubMed ID: 25587654
[TBL] [Abstract][Full Text] [Related]
14. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
Coskun M; Salem M; Pedersen J; Nielsen OH
Pharmacol Res; 2013 Oct; 76():1-8. PubMed ID: 23827161
[TBL] [Abstract][Full Text] [Related]
15. Janus kinase/signal transducer and activator of transcription pathways in spondyloarthritis.
Raychaudhuri SK; Raychaudhuri SP
Curr Opin Rheumatol; 2017 Jul; 29(4):311-316. PubMed ID: 28394822
[TBL] [Abstract][Full Text] [Related]
16. Inteferons pen the JAK-STAT pathway.
Schindler C; Plumlee C
Semin Cell Dev Biol; 2008 Aug; 19(4):311-8. PubMed ID: 18765289
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Janus Kinase Family in Autoimmune Skin Diseases.
Howell MD; Kuo FI; Smith PA
Front Immunol; 2019; 10():2342. PubMed ID: 31649667
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis.
Benveniste EN; Liu Y; McFarland BC; Qin H
J Interferon Cytokine Res; 2014 Aug; 34(8):577-88. PubMed ID: 25084174
[TBL] [Abstract][Full Text] [Related]
19. Double-edged sword of JAK/STAT signaling pathway in viral infections: novel insights into virotherapy.
Mahjoor M; Mahmoudvand G; Farokhi S; Shadab A; Kashfi M; Afkhami H
Cell Commun Signal; 2023 Oct; 21(1):272. PubMed ID: 37784164
[TBL] [Abstract][Full Text] [Related]
20. The role of JAK/STAT signaling pathway and its inhibitors in diseases.
Xin P; Xu X; Deng C; Liu S; Wang Y; Zhou X; Ma H; Wei D; Sun S
Int Immunopharmacol; 2020 Mar; 80():106210. PubMed ID: 31972425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
